DXB are gunnahave to pull a rabbit out of the hat to get the SP to 8c before the close ofthe Cap Raise to make it attractive for SH to want to unquestionably participate? Do they have one?
With thecurrent SP at ~7.3c - the two for one options (unlisted and listed) supposedsweetener still does not make participation look that attractive. The immediate value of the oppies would struggle to be equal to 0.8c in value. Sure, if/when the Ph3 trial is a success then bingo those oppies will be in the money but it is a bit hard to swallow paying 8c for a share with diluted freebie oppies when the market isn’t that excited to purchase the heads on market at a discounted 7.3c.
It is a direposition we long term SH are in and if there is poor take up on the SP as theknock on effect is then to the health of the Co. itself. I am concerned of how they plan to get out of this quagmire they have created.
- Forums
- ASX - By Stock
- DXB
- Ann: Entitlement offer and Convertible Note to raise $12 million
Ann: Entitlement offer and Convertible Note to raise $12 million, page-16
Featured News
Add DXB (ASX) to my watchlist
(20min delay)
|
|||||
Last
37.5¢ |
Change
0.000(0.00%) |
Mkt cap ! $206.3M |
Open | High | Low | Value | Volume |
38.0¢ | 38.5¢ | 36.5¢ | $579.4K | 1.548M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 91570 | 37.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
37.5¢ | 7922 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 237 | 0.395 |
1 | 25000 | 0.375 |
1 | 91570 | 0.370 |
11 | 173185 | 0.365 |
15 | 330276 | 0.360 |
Price($) | Vol. | No. |
---|---|---|
0.365 | 3916 | 1 |
0.375 | 24289 | 3 |
0.380 | 122644 | 6 |
0.385 | 28104 | 2 |
0.390 | 46769 | 5 |
Last trade - 16.10pm 15/11/2024 (20 minute delay) ? |
Featured News
DXB (ASX) Chart |
The Watchlist
ACW
ACTINOGEN MEDICAL LIMITED
Will Souter, CFO
Will Souter
CFO
Previous Video
Next Video
SPONSORED BY The Market Online